Susquehanna International Group, LLP Atai Life Sciences N.V. Call Options Transaction History

Susquehanna International Group, LLP

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 07, 2024	BUY	$1.5 - $2.19 $172,350 - $251,631	114,900 Added 309.7%	152,000 $299,000
Q4 2023 Feb 14, 2024	SELL	$1.04 - $1.55 $31,304 - $46,655	-30,100 Reduced 44.79%	37,100 $52,000
Q3 2023 Nov 14, 2023	SELL	$1.27 - $2.28 $162,052 - $290,928	-127,600 Reduced 65.5%	67,200 $86,000
Q2 2023 Aug 11, 2023	BUY	$1.44 - $2.19 $108,864 - $165,564	75,600 Added 63.42%	194,800 $335,000
Q1 2023 May 16, 2023	BUY	$1.17 - $2.7 $46,449 - $107,190	39,700 Added 49.94%	119,200 $215,000
Q4 2022 Feb 14, 2023	SELL	$2.38 - $3.55 $256,802 - $383,045	-107,900 Reduced 57.58%	79,500 $211,000
Q3 2022 Nov 14, 2022	SELL	$3.14 - $4.87 $3,140 - $4,870	-1,000 Reduced 0.53%	187,400 $620,000
Q2 2022 Aug 15, 2022	SELL	$3.03 - $5.32 $32,723 - $57,456	-10,800 Reduced 5.42%	188,400 $686,000
Q1 2022 May 16, 2022	BUY	$4.66 - $7.66 $627,236 - $1.03 Million	134,600 Added 208.36%	199,200 $1.01 Million
Q4 2021 Feb 14, 2022	BUY	$6.82 - $17.8 $319,176 - $833,040	46,800 Added 262.92%	64,600 $493,000
Q3 2021 Nov 15, 2021	BUY	$13.62 - $19.48 $242,436 - $346,744	17,800 New	17,800 $263,000

12.8M

9.2K

118K

Ticker ATAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 165,875,008
Market Cap $224M
Description
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.